LTE-15174


Study NameStudy TitleStudy TypeSponsorSponsor Type
LTE-15174ATLAS-OLE: An Open-label, Long-term Safety and Efficacy Study of Fitusiran in Patients with Hemophilia A or B, with or without Inhibitory Antibodies to Factor VIII or IXClinical Trial of IMPGenzyme CorporationIndustry supported